Half the rate of the initial dose
The most common concentrations include 2.5mg/mL (typically in smaller 1 mL vials containing 2.5 mg total), 5mg/mL (in 1 mL vials containing 5 mg total or 2 mL vials containing 10 mg total), and occasionally higher concentrations for patients on maintenance doses
Its not for the needle-shy
Risks include nausea, digestive discomfort, and potential hormonal side effects
Research suggests GIP activation improves insulin sensitivity in adipose tissue, may contribute to central nervous system appetite regulation beyond what GLP-1 provides, and appears to reduce some of the gastrointestinal side effects associated with GLP-1 agonism alone
The failures to develop drugs to modulate other hormones reflect the complexity and redundancy of the biochemical signals that control our need to eat, says Linda Shapiro, the chief medical officer of Rhythm Pharmaceuticals, a company that specializes in weight-loss drugs for people who have genetic mutations that cause weight gain